These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28862075)

  • 21. Meprin metalloproteases: Molecular regulation and function in inflammation and fibrosis.
    Arnold P; Otte A; Becker-Pauly C
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2096-2104. PubMed ID: 28502593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
    Marondedze EF; Govender KK; Govender PP
    J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliable structural information for rational design of benzoxazole type potential cholesteryl ester transfer protein (CETP) inhibitors through multiple validated modeling techniques.
    Amin SA; Adhikari N; Gayen S; Jha T
    J Biomol Struct Dyn; 2019 Oct; 37(17):4528-4541. PubMed ID: 30488780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and Optimization of Selective Inhibitors of Meprin α (Part I).
    Hou S; Diez J; Wang C; Becker-Pauly C; Fields GB; Bannister T; Spicer TP; Scampavia LD; Minond D
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33671080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors.
    Jha T; Adhikari N; Saha A; Amin SA
    SAR QSAR Environ Res; 2018 Jan; 29(1):43-68. PubMed ID: 29254380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities.
    Bylander JE; Bertenshaw GP; Matters GL; Hubbard SJ; Bond JS
    Biol Chem; 2007 Nov; 388(11):1163-72. PubMed ID: 17976009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of structural alerts and fingerprints for novel anticancer therapeutics: a robust classification-QSAR dependent structural analysis of drug-like MMP-9 inhibitors.
    Banerjee S; Baidya SK; Ghosh B; Jha T; Adhikari N
    SAR QSAR Environ Res; 2023 Apr; 34(4):299-319. PubMed ID: 37170840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of dual-target natural inhibitors of meprins α and β metalloproteases for inflammation regulation: pharmacophore modelling, molecular docking, ADME prediction, and molecular dynamics studies.
    Eltaib L; Alzain AA
    SAR QSAR Environ Res; 2023 Nov; ():1-23. PubMed ID: 37955603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent beta-secretase inhibitory leads.
    Al-Nadaf A; Abu Sheikha G; Taha MO
    Bioorg Med Chem; 2010 May; 18(9):3088-115. PubMed ID: 20378363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metalloprotease meprin β is activated by transmembrane serine protease matriptase-2 at the cell surface thereby enhancing APP shedding.
    Jäckle F; Schmidt F; Wichert R; Arnold P; Prox J; Mangold M; Ohler A; Pietrzik CU; Koudelka T; Tholey A; Gütschow M; Stirnberg M; Becker-Pauly C
    Biochem J; 2015 Aug; 470(1):91-103. PubMed ID: 26251449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the epithelial sodium channel by the metalloprotease meprin β subunit.
    Garcia-Caballero A; Ishmael SS; Dang Y; Gillie D; Bond JS; Milgram SL; Stutts MJ
    Channels (Austin); 2011; 5(1):14-22. PubMed ID: 20953144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
    Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated QSAR modeling approach to explore the structure-property and selectivity relationships of N-benzoyl-L-biphenylalanines as integrin antagonists.
    Amin SA; Adhikari N; Bhargava S; Gayen S; Jha T
    Mol Divers; 2018 Feb; 22(1):129-158. PubMed ID: 29147824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of meprin β controls its cell surface abundance and subsequently diminishes ectodomain shedding.
    Armbrust F; Bickenbach K; Koudelka T; Tholey A; Pietrzik C; Becker-Pauly C
    FASEB J; 2021 Jul; 35(7):e21677. PubMed ID: 34125978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemometric design to explore pharmacophore features of BACE inhibitors for controlling Alzheimer's disease.
    Hossain T; Mukherjee A; Saha A
    Mol Biosyst; 2015 Feb; 11(2):549-57. PubMed ID: 25435329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights from Analysis of Binding Sites of Human Meprins: Screening of Inhibitors by Molecular Dynamics Simulation Study.
    Chaudhuri A; Bera AK; Sarkar I; Chakraborty S
    Comb Chem High Throughput Screen; 2016; 19(3):246-58. PubMed ID: 26875789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A kinetic comparison of the homologous proteases astacin and meprin A.
    Wolz RL
    Arch Biochem Biophys; 1994 Apr; 310(1):144-51. PubMed ID: 8161197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted disruption of the meprin metalloproteinase beta gene protects against renal ischemia-reperfusion injury in mice.
    Bylander J; Li Q; Ramesh G; Zhang B; Reeves WB; Bond JS
    Am J Physiol Renal Physiol; 2008 Mar; 294(3):F480-90. PubMed ID: 18172000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
    Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
    Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.